Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats

Metabolism: Clinical and Experimental

Volumn 47, Issue 7, 1998, Pages 783-787

  Sugimoto, Miyuki ^a   Takeda, Noriyuki ^a   Nakashima, Kazuya ^a   Okumura, Shoji ^a   Takami, Kazuhisa ^a   Yoshino, Kouji ^a   Hattori, Junko ^a   Ishimori, Masatoshi ^a   Takami, Rieko ^a   Sasaki, Akihiko ^a   Yasuda, Keigo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; FATTY ACID; GLUCOSE; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; RECOMBINANT GROWTH HORMONE; TROGLITAZONE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GROWTH HORMONE RELEASE; INSULIN RESISTANCE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECOMBINANT GENE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 13144305046     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90112-3     Document Type: Article

References (34)

1. Kaplan SL: The newer uses of growth hormone in adults. Adv Intern Med 38:287-301, 1993
2. Lippe BM, Nakamoto JM: Conventional and nonconventional uses of growth hormone. Rec Prog Horm Res 48:179-235, 1993
3. Czernichow P, Albertsson-Wikland K, Tuvemo T, et al: Growth hormone treatment and diabetes: Survey of the Kabi Pharmacia International Growth Study. Acta Paediatr Scand 379:104-107, 1991 (suppl)
4. Ganda OP, Simonson DC: Growth hormone, acromegaly, and diabetes. Diabetes Rev 1:286-300, 1993
5. Rizza RA, Mandarino LJ, Gerich JE: Effects of growth hormone on insulin action in man: Mechanism of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31:663-669, 1982
6. Bratusch-Marrain PR, Smith D, DeFronzo RA: The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55:973-982, 1982
7. Fujita T, Sugiyama Y, Taketomi S et al: Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohex-yhnethoxy) benzyl]-thiazolidine-2,4-dione (ADA-3878, U-63,287, ciglitazone), a new antidiabetic agent. Diabetes 32:804-810, 1983
8. Fujiwara T, Yoshioka S, Yoshioka T et al: Characterization of new oral antidiabetic agent CS-045: Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37:1549-1558, 1988
9. Lee MK, Miles PDG, Khoursheed M, et al: Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes 43:1435-1439, 1994
10. Oakes ND, Kennedy CJ, Jenkins AB, et al: A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 43:1203-1210, 1994
11. Kellerer M, Kroder G, Tippmer S, et al: Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes 43:447-453, 1994
12. Towns R, Kostyo JL, Colca JR: Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth. Endocrinology 134:608-613, 1994
13. Terrettaz J, Jeanrenaud B: In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats. Endocrinology 112:1346-1351, 1983
14. Ng SF, Storlien LH, Kraegen EW, et al: Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in vivo. Metabolism 39:264-268, 1990
15. Neely RDG, Rooney DP, Bell PM, et al: Influence of growth hormone on glucose-glucose 6-phosphate cycle and insulin action in normal humans. Am J Physiol 263:E980-E987, 1992
16. Cartee GD, Bohn EE: Growth hormone reduces glucose trans-port but not GLUT-1 or GLUT-4 in adult and old rats. Am J Physiol 268:E902-E909, 1995
17. Hettiarachchi M, Watkinson A, Jenkins AB, et al: Growth hormone-induced insulin resistance and its relationship to Iipid availability in the rat. Diabetes 45:415-421, 1996
18. Ørskov L, Schmilz O, Jørgensen JOL, et al: Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique. J Clin Endocrinol Metab 68:276-282, 1989
19. Møller N, Jørgensen JOL, Alberti KGMM, et al: Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab 70:1179-1186, 1990
20. Suter SL, Nolan JJ, Wallace P, et al: Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 15:193-203, 1992
21. Møller N, Jørgensen JOL, Abildgård L, et al: Effects of growth hormone on glucose metabolism. Horm Res 36:32-35,1991 (suppl 1)
22. Davidson MB: Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131, 1987
23. Argetsinger L, Carter-Su C: Mechanism of signaling by growth hormone receptor. Physiol Rev 76:1089-1107, 1996
24. Magri KA, Adamo M, Leroith D, et al: The inhibition of insulin action and glucose metabolism by porcine growth hormone in porcine adipocytes is not the result of any decrease in insulin binding or insulin receptor kinase activity. Biochem J 266:107-113, 1990
25. Venkatesan N, Davidson MB: Insulin resistance in rats harboring growth hormone-secreting tumors: Decreased receptor number but increased kinase activity in liver. Metabolism 44:75-84, 1995
26. Tai PK, Liao JF, Chen EH, et al: Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells. J Biol Chem 265:21828-21834, 1990
27. Imamura H, Morimoto I, Etoh S, et al: Skeletal muscle glucose transporter gene expression is not affected by injecting growth-hormone-secreting cells in young rats. Diabetologia 36:475-480, 1993
28. Kobayashi M, Iwanishi M, Egawa K, et al: Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41:476-483, 1992
29. Turnbow MA, Smith LK, Garner CW: The oxazolidinedione CP-92,768-2 partially protects insulin receptor substrate-1 from dexamethasone down-regulation in 3T3-L1 adipocytes. Endocrinology 136:1450-1458, 1995
30. Sizer KM, Smith CL, Jacobb CS et al: Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3-L1 adipocytes by inhibiting a negative control mechanism. Mol Cell Endocrinol 102:119-129, 1994
31. Zhang B, Szalkowski D, Diaz E, et al: Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedionederived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. J Biol Chem 269:25735-25741, 1994
32. Hoffmann C, Lorenz K, Colca JR: Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. Endocrinology 129:1915-1925, 1991
33. El-Kebbi IM, Roser S, Pollet RJ: Regulation of glucose transport by pioglitazone in cultured muscle cells. Metabolism 43:953-958, 1994
34. Ciaraldi TP, Huber-Knudsen K, Hickman M, et al: Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents. Metabolism 44:976-982, 1995